Cradle Secures $73M Series B to Advance AI Protein Engineering
Slice of Healthcare Team
12/02/2024
Key Highlights
- $73M Series B funding led by IVP, with support from Index Ventures and Kindred Capital.
- Total funding exceeds $100M, accelerating Cradle’s vision for global AI-driven protein engineering.
- Cradle’s AI models enable 1.2-12x faster R&D and up to 90% cost reductions.
- Trusted by industry leaders like Novo Nordisk, Johnson & Johnson, Novonesis, and Grifols.
- New Chief Commercial Officer Sam Partovi joins as the 40th team member to drive growth.
Source: Direct
Notable Quote
“ Biology is one of the domains where generative AI can have the biggest positive impact, and Cradle is leading the way with its pioneering approach to protein design as a digital service. ”
Alex Lim, General Partner at IVP
